NCT04254354 Transgender Men, Non-binary Persons and Testosterone Treatment BODY IDENTITY CLINIC
| NCT ID | NCT04254354 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Marianne Andersen |
| Condition | Transgenderism |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2020-03-03 |
| Primary Completion | 2044-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2020-03-03 with a primary completion date of 2044-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to investigate transgender men and non-binary persons before and during testosterone treatment. The study will focus on: * Cardiovascular status * Muscle strenght and power * Aggression and quality of life * Cardiac and respiratory function
Eligibility Criteria
Inclusion Criteria: Transgender men Exclusion Criteria: none
Contact & Investigator
Marianne Andersen
PRINCIPAL INVESTIGATOR
Odense University Hospital
Frequently Asked Questions
Who can join the NCT04254354 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Transgenderism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04254354 currently recruiting?
Yes, NCT04254354 is actively recruiting participants. Contact the research team at msa@rsyd.dk for enrollment information.
Where is the NCT04254354 trial being conducted?
This trial is being conducted at Odense, Denmark.
Who is sponsoring the NCT04254354 clinical trial?
NCT04254354 is sponsored by Marianne Andersen. The principal investigator is Marianne Andersen at Odense University Hospital. The trial plans to enroll 200 participants.